SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group (CAR) is currently gripped by an extreme short squeeze, with community discussion centered on its highly constrained float and reports that a small group of institutional holders control a majority of the shares. While many traders are enjoying significant gains from the stock's parabolic ascent, others are cautioning that the rampant volatility, frequent trading halts, and the potential for a share offering or institutional profit-taking make this a high-stakes, dangerous game of musical chairs.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending due to significant institutional interest and anticipation surrounding its role in the unfolding AI infrastructure supercycle, as investors weigh its potential to compete with major semiconductor peers. The community is actively debating the stock's recent price appreciation, with bulls pointing to strong CPU and GPU demand, while others caution against overstretched valuations following a prolonged period of positive momentum.

Velo3D, Inc. operates as a technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer & sapphire XC. The company was founded by Benyamin Buller in June 2014 and is headquartered in Fremont, CA.

Velo3D Inc

Velo3D is surging on heavy volume as investors react to a significant multi-year contract with the Department of War and growing anticipation around the company's deepening ties to key aerospace and defense players. The community is actively debating the stock's massive short interest and potential for a squeeze against concerns over future capital raises and dilution, while bulls highlight the critical nature of its additive manufacturing technology for mission-ready defense production.

American Airlines Group, Inc. is a holding company, which engages in the operation of a network carrier through its principal wholly owned mainline operating subsidiary, American. The firm offers air transportation for passengers and cargo. It operates through the following geographical segments: Domestic, Latin America, Atlantic, and Pacific. The company was founded on December 9, 2013, and is headquartered in Fort Worth, TX.

American Airlines Group Inc

American Airlines is trending as investors grapple with the airline's significant debt load, rising jet fuel costs, and recent volatility sparked by merger rumors and regional geopolitical instability. The community is actively debating the stock's long-term viability, with many closely tracking updates on potential conflict-related supply disruptions and the company's ability to manage fuel-intensive operations.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals is currently a focal point for investors due to intensifying acquisition speculation and consistent institutional buying patterns, which have created a tightly compressed trading range. While the community debates the validity of buyout rumors and critiques the company's long-term performance, high levels of dark pool activity and heavy option volume suggest sophisticated market participants are positioning for a potential catalyst.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Investors are actively debating whether the semiconductor sector is currently in a parabolic bubble or if the relentless streak of green days is a temporary distortion, leading to significant frustration among those shorting the stock. Community sentiment is deeply polarized as traders weigh the impact of geopolitical headlines, upcoming earnings reports, and the aggressive upward momentum of the sector.

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is seeing significant volatility driven by intense community debate over a potential short squeeze, with investors closely watching for a major data center contract to validate the firm's pivot toward AI infrastructure. While bulls emphasize technical breakout patterns and growing pipeline opportunities, bears remain vocal about persistent share dilution and the absence of definitive new deals.

T-Mobile US, Inc. engages in the provision of wireless communications services under the T-Mobile and MetroPCS brands. It offers postpaid and prepaid wireless voice, messaging and data services, and wholesale wireless services. The company was founded in 1994 and is headquartered in Bellevue, WA.

T-Mobile US Inc

T-Mobile is trending following a strong quarterly performance where it exceeded earnings estimates and raised its forward guidance, though the stock has faced localized selling pressure. The community is actively debating the company's competitive momentum against Verizon and AT&T, while investors are closely analyzing recent institutional activity and technical support levels.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is seeing a significant surge in momentum driven by aggressive institutional accumulation and positive commentary from the CFO regarding production orders and hyperscaler integration. The community is actively dismissing recent short-seller reports, focusing instead on the company's role as a key supplier in the high-growth AI optical interconnect market.

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the line of branded generic pharmaceuticals manufactured worldwide and marketed and sold outside the United States in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternate care testing sites. The Nutritional Products segment caters to the worldwide sales of pediatric and adult nutritional products. The Medical Devices segment includes a broad line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care and continuous glucose monitoring products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Abbott Laboratories

Abbott Laboratories is experiencing significant market attention following its earnings report and the strategic $23 billion acquisition of Exact Sciences. While the company faces pressure from adjusted growth guidance and ongoing litigation concerns, investors remain focused on long-term value, with many discussing the stock's potential for a re-rating as they navigate the integration of its expanded diagnostics footprint.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Delcath Systems, Inc. (NASDAQ:DCTH) Given Consensus Rating of "Moderate Buy" by Brokerages

Delcath Systems, Inc. (NASDAQ:DCTH - Get Free Report) has been given an average rating of "Moderate Buy" by the six brokerages that are currently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell rating and five have issued a buy rating on the com...

JPMorgan Chase & Co. Decreases Position in Delcath Systems, Inc. $DCTH

JPMorgan Chase & Co. cut its position in Delcath Systems, Inc. (NASDAQ:DCTH - Free Report) by 92.6% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 12,501 shares of the company's stock after selling 155,744 shares during the period. JPMorgan Chase & Co.'s ho...

Delcath Systems (NASDAQ:DCTH) Stock Price Up 0.3% - Time to Buy?

Delcath Systems (NASDAQ:DCTH) Shares Up 0.3% - Should You Buy...

Implied Volatility Surging for Delcath Systems Stock Options

Investors need to pay close attention to DCTH stock based on the movements in the options market lately.

Delcath Systems, Inc. Announces Inclusion of CHEMOSAT Hepatic Delivery System for Melphalan as a Recommended Liver-Directed Regional Therapy Option in the ESMOEURACAN Clinical Practice Guidelines for Uveal Melanoma

Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on liver-directed cancer therapies, today announced that its proprietary CHEMOSAT Hepatic Delivery System for...

Delcath Systems to Participate at the Society of Interventional Radiology 2026 Meeting

Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, will attend the Society of Interventional Radiology...

Delcath Systems, Inc. (NASDAQ:DCTH) Given Average Rating of "Moderate Buy" by Brokerages

Shares of Delcath Systems, Inc. (NASDAQ:DCTH - Get Free Report) have earned an average recommendation of "Moderate Buy" from the six ratings firms that are currently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell rating and five have issued a buy ra...

Divisadero Street Capital Management LP Invests $5.12 Million in Delcath Systems, Inc. $DCTH

Divisadero Street Capital Management LP purchased a new position in Delcath Systems, Inc. (NASDAQ:DCTH - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with...

Propel Bio Management LLC Buys 212,457 Shares of Delcath Systems, Inc. $DCTH

Propel Bio Management LLC grew its stake in shares of Delcath Systems, Inc. (NASDAQ:DCTH - Free Report) by 94.0% during the third quarter, according to its most recent filing with the Securities and...

Delcath Systems Announces Publication of CHOPIN Clinical Trial Results in The Lancet Oncology

Delcath Systems, Inc. (Nasdaq: DCTH), (Delcath or the Company) an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced the publication of...

Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.

DCTH
Delcath Systems Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest DCTH News

DCTHDelcath Systems Inc